Avient 과거 순이익 실적
과거 기준 점검 3/6
Avient의 수입은 연평균 -8.5%의 비율로 감소해 온 반면, Chemicals 산업은 수입이 연평균 3.8% 감소했습니다. 매출은 연평균 1.8%의 비율로 감소해 왔습니다. Avient의 자기자본이익률은 6.6%이고 순이익률은 4.8%입니다.
핵심 정보
-8.55%
순이익 성장률
-8.56%
주당순이익(EPS) 성장률
| Chemicals 산업 성장률 | 12.93% |
| 매출 성장률 | -1.82% |
| 자기자본이익률 | 6.59% |
| 순이익률 | 4.81% |
| 최근 순이익 업데이트 | 31 Mar 2026 |
최근 과거 실적 업데이트
Recent updates
내러티브 업데이트 • Apr 22
AVNT: Future Crude Linked Cost Controls Will Support ReRating Potential
Analysts have maintained Avient’s fair value estimate at $48.57 while refining assumptions, including a slightly lower discount rate. This reflects recent price target increases from several firms, alongside a more cautious sector stance from others.내러티브 업데이트 • Apr 08
AVNT: Future Crude Linked Cost Management Will Drive ReRating Potential
Analysts have modestly adjusted their price target on Avient to $48.57, with updated assumptions reflecting a slightly lower discount rate and broadly unchanged expectations for revenue growth, profit margins, and future P/E. Recent Street research cites higher crude linked input costs and mixed sector views, alongside higher individual firm targets up to $52.내러티브 업데이트 • Mar 24
AVNT: Future Commodity Cost Management Will Drive ReRating Potential
Narrative Update The updated analyst price target for Avient edges lower by about $1, reflecting slightly higher discount rate assumptions and cautious views on raw material cost pressures. This comes even as several firms have recently lifted their individual targets following earnings and valuation roll-forwards.내러티브 업데이트 • Mar 08
AVNT: Future End Market Recovery And Higher P/E Are Expected To ReRate Shares
Narrative Update on Avient Our analyst price target for Avient edges up from $48.25 to $49.50 as analysts cite updated valuation work, including higher forward price targets and refined expectations for revenue growth, profit margins and future P/E multiples following recent sector and company specific research. Analyst Commentary Recent research on Avient shows a mix of optimism about the longer term setup and caution around near term input cost and industry headwinds.내러티브 업데이트 • Feb 21
AVNT: Demand Recovery In Key End Markets Will Drive Future Multiple
The analyst fair value estimate for Avient has moved from $41.75 to $48.25, reflecting higher Street price targets as analysts update their models and adjust assumptions around future revenue growth, profit margins, and P/E multiples. Analyst Commentary Street research on Avient over the past few months has centered on revised valuation frameworks, longer dated earnings assumptions, and how quickly demand in key end markets might stabilize.분석 기사 • Feb 19
There May Be Reason For Hope In Avient's (NYSE:AVNT) Disappointing Earnings
Avient Corporation's ( NYSE:AVNT ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...Seeking Alpha • Feb 18
Avient: Becoming A Better Business
Summary Avient has demonstrated solid operating momentum and resilient execution, with shares enjoying a notable re-rating amid challenging industry conditions. Avient's 2026 outlook targets adjusted EBITDA of $555–$585 million and an adjusted EPS midpoint of $3.05, driven by productivity and innovation, not macro recovery. Leverage has improved to 2.6x, and valuation has expanded to 14x adjusted earnings, reflecting investor confidence in management's strategy and product pipeline. Despite a 30% share price gain in six months, Avient remains reasonably valued, but further upside may prompt position trimming on strength. Read the full article on Seeking Alpha
새 내러티브 • Feb 16
Defense And Healthcare Materials Will Drive A Stronger Long Term Outlook
Catalysts About Avient Avient supplies specialized materials and color and additive solutions for end markets such as health care, defense, telecommunications, packaging and transportation. What are the underlying business or industry changes driving this perspective?내러티브 업데이트 • Feb 06
AVNT: Fair View Suggests Demand Recovery And Margins Will Drive Future Multiple
Narrative Update on Avient The analyst price target for Avient has been updated to US$41.75, a US$4.75 increase from the prior US$37 level. This change reflects a combination of higher targets from some firms and lower targets from others, as well as modest adjustments to assumptions for discount rate, revenue growth, profit margin and future P/E.내러티브 업데이트 • Jan 23
AVNT: Fair View Suggests Execution Will Shape Future Multiple Potential
Narrative Update on Avient The analyst price target for Avient has been adjusted slightly higher from $41.00 to $41.75, reflecting analysts’ updated views on earnings quality and valuation following recent target changes across the Street. Analyst Commentary Recent research updates on Avient present a mixed picture, with some analysts lifting targets and others trimming them, reflecting different views on how the company might execute in a challenging industry setup.내러티브 업데이트 • Jan 08
AVNT: Reset Price View Will Support Future Multiple Expansion
Narrative Update Overview Analysts have trimmed their price target on Avient to US$36 from US$42, reflecting updated views on the shares while maintaining broadly consistent assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary Recent commentary on Avient centers on the reset in the price target to US$36.내러티브 업데이트 • Dec 23
AVNT: Dividend And Buyback Execution Will Support Future Multiple Expansion
Avient's analyst price target has been reduced by $6 to $36, as analysts factor in more conservative expectations for the shares while maintaining a positive long term outlook. Analyst Commentary Analysts are recalibrating their expectations for Avient, balancing a still constructive long term view on execution and earnings power with a more tempered near term valuation framework.내러티브 업데이트 • Dec 09
AVNT: New Leadership Will Drive 4% Organic Expansion As Cyclical Headwinds Ease
Avient's updated analyst price target has edged lower, reflecting a recalibration toward the mid 30 dollar to high 40 dollar range as analysts balance near term macro and cyclical pressures against improving margin prospects and the potential for faster organic growth under the new strategic focus. Analyst Commentary Recent Street research reflects a balanced mix of optimism around Avient's strategic pivot and caution on near term earnings power, resulting in a wide but grounded valuation range.내러티브 업데이트 • Nov 24
AVNT: Renewed Leadership Will Drive Recovery With 4% Organic Expansion Ahead
Analysts have trimmed their price target for Avient by $1.13 to $41.00. This reflects cautious sentiment following reduced profit margin forecasts and recent reassessments of growth potential.내러티브 업데이트 • Nov 07
AVNT: Renewed Leadership Will Drive Recovery In High-Growth End Markets
Analysts have modestly reduced their fair value estimate for Avient from $43.25 to $42.13. They cite a more conservative revenue growth outlook, even though profit margins and long-term growth opportunities continue to be supported by recent positive coverage and management strategy shifts.분석 기사 • Nov 05
Avient (NYSE:AVNT) Will Pay A Larger Dividend Than Last Year At $0.275
The board of Avient Corporation ( NYSE:AVNT ) has announced that the dividend on 7th of January will be increased to...분석 기사 • Oct 12
Avient (NYSE:AVNT) Is Increasing Its Dividend To $0.275
Avient Corporation's ( NYSE:AVNT ) dividend will be increasing from last year's payment of the same period to $0.275 on...내러티브 업데이트 • Sep 18
High-Performance Healthcare Materials And Sustainable Polymers Will Create Value
Analysts have raised Avient’s price target to $43.25, citing increased confidence in the new CEO’s strategic focus on high-growth markets, anticipated organic growth, and recovery potential in cyclical end markets. Analyst Commentary Increased optimism due to the new CEO's strategic focus on high-growth platforms and markets.분석 기사 • Sep 13
Avient Corporation's (NYSE:AVNT) Earnings Haven't Escaped The Attention Of Investors
With a price-to-earnings (or "P/E") ratio of 27.9x Avient Corporation ( NYSE:AVNT ) may be sending bearish signals at...분석 기사 • Jul 14
Are Investors Undervaluing Avient Corporation (NYSE:AVNT) By 30%?
Key Insights Avient's estimated fair value is US$48.56 based on 2 Stage Free Cash Flow to Equity Current share price of...분석 기사 • May 23
Is Avient Corporation (NYSE:AVNT) Potentially Undervalued?
Avient Corporation ( NYSE:AVNT ), might not be a large cap stock, but it saw a significant share price rise of 25% in...분석 기사 • May 08
Is Avient (NYSE:AVNT) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...분석 기사 • Apr 07
Is There An Opportunity With Avient Corporation's (NYSE:AVNT) 49% Undervaluation?
Key Insights Avient's estimated fair value is US$60.06 based on 2 Stage Free Cash Flow to Equity Avient's US$30.43...분석 기사 • Mar 23
Some Confidence Is Lacking In Avient Corporation's (NYSE:AVNT) P/E
With a price-to-earnings (or "P/E") ratio of 20.7x Avient Corporation ( NYSE:AVNT ) may be sending bearish signals at...Seeking Alpha • Mar 22
Avient: Specialty Play Slowly Becomes More Special
Summary Avient Corporation has returned to growth in 2024, with promising projections for 2025, despite past disappointments and mixed earnings metrics. The company, specializing in material solutions, aims for organic growth and 20% EBITDA margins, but hasn't yet achieved these targets. Trading at $38 per share, Avient's valuation appears reasonable, but earnings will again be highly adjusted due to significant charges. While the 2025 outlook is strong, I remain cautious and seek a better entry point before initiating a long position. Read the full article on Seeking Alpha분석 기사 • Feb 19
At US$44.21, Is Avient Corporation (NYSE:AVNT) Worth Looking At Closely?
While Avient Corporation ( NYSE:AVNT ) might not have the largest market cap around , it saw a decent share price...분석 기사 • Jan 20
Does Avient (NYSE:AVNT) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...분석 기사 • Jan 03
An Intrinsic Calculation For Avient Corporation (NYSE:AVNT) Suggests It's 31% Undervalued
Key Insights Avient's estimated fair value is US$57.96 based on 2 Stage Free Cash Flow to Equity Avient is estimated to...분석 기사 • Dec 18
Earnings Tell The Story For Avient Corporation (NYSE:AVNT)
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 18x, you may...분석 기사 • Nov 18
Is It Time To Consider Buying Avient Corporation (NYSE:AVNT)?
Avient Corporation ( NYSE:AVNT ), is not the largest company out there, but it saw a decent share price growth of 13...Seeking Alpha • Nov 13
Avient: Specialization Strategy Is Growing Margins And Driving The Bottom-Line Growth
Summary AVNT's gross profit margins have improved by over 70% in the last decade, indicating a shift to higher-margin specialty services. The company is focused on deleveraging, with share repurchases on hold until net debt-to-EBITDA reaches 2.5x, despite recent acquisitions. AVNT announced its 14th consecutive annual dividend increase, with a 5% hike, and aims to return to a safer payout ratio by 2026. With projected double-digit EPS growth and a potential P/E Ratio of 20.6x, AVNT is rated as a BUY with an estimated share price of $61.80 by the 2025 year-end. Read the full article on Seeking Alpha분석 기사 • Nov 02
Avient's (NYSE:AVNT) Dividend Will Be Increased To $0.27
Avient Corporation's ( NYSE:AVNT ) dividend will be increasing from last year's payment of the same period to $0.27 on...분석 기사 • Sep 26
Avient (NYSE:AVNT) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
새 내러티브 • Sep 02
Navigating Challenges, The Company Leverages Healthcare Innovations And Tactical Partnerships For Growth
Avient's strategy focuses on market share gain in varied sectors, especially healthcare, promising revenue growth with innovations like drug delivery devices.분석 기사 • Aug 03
A Look At The Intrinsic Value Of Avient Corporation (NYSE:AVNT)
Key Insights Avient's estimated fair value is US$37.54 based on 2 Stage Free Cash Flow to Equity With US$42.83 share...매출 및 비용 세부 내역
매출 및 비용 세부 내역
Avient가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.
순이익 및 매출 추이
| 날짜 | 매출 | 순이익 | 일반관리비 | 연구개발비 |
|---|---|---|---|---|
| 31 Mar 26 | 3,281 | 158 | 687 | 0 |
| 31 Dec 25 | 3,260 | 82 | 701 | 0 |
| 30 Sep 25 | 3,246 | 113 | 707 | 0 |
| 30 Jun 25 | 3,255 | 119 | 713 | 0 |
| 31 Mar 25 | 3,238 | 100 | 720 | 0 |
| 31 Dec 24 | 3,240 | 170 | 713 | 0 |
| 30 Sep 24 | 3,213 | 149 | 689 | 0 |
| 30 Jun 24 | 3,151 | 116 | 666 | 0 |
| 31 Mar 24 | 3,126 | 104 | 659 | 0 |
| 31 Dec 23 | 3,143 | 76 | 672 | 0 |
| 30 Sep 23 | 3,214 | 31 | 715 | 0 |
| 30 Jun 23 | 3,284 | -1 | 709 | 0 |
| 31 Mar 23 | 3,350 | 39 | 691 | 0 |
| 31 Dec 22 | 3,397 | 83 | 653 | 0 |
| 30 Sep 22 | 3,414 | 108 | 631 | 0 |
| 30 Jun 22 | 3,408 | 169 | 639 | 0 |
| 31 Mar 22 | 3,045 | 137 | 631 | 0 |
| 31 Dec 21 | 3,316 | 152 | 661 | 0 |
| 30 Sep 21 | 3,506 | 218 | 655 | 0 |
| 30 Jun 21 | 3,612 | 186 | 665 | 0 |
| 31 Mar 21 | 3,693 | 178 | 617 | 0 |
| 31 Dec 20 | 2,215 | 71 | 506 | 0 |
| 30 Sep 20 | 2,904 | 64 | 474 | 0 |
| 30 Jun 20 | 2,685 | 86 | 418 | 0 |
| 31 Mar 20 | 2,824 | 86 | 442 | 0 |
| 31 Dec 19 | 2,863 | 76 | 486 | 0 |
| 30 Sep 19 | 2,881 | 68 | 483 | 0 |
| 30 Jun 19 | 2,905 | 77 | 474 | 0 |
| 31 Mar 19 | 2,730 | 62 | 452 | 0 |
| 31 Dec 18 | 2,881 | 88 | 456 | 0 |
| 30 Sep 18 | 3,005 | 124 | 451 | 0 |
| 30 Jun 18 | 3,094 | 132 | 450 | 0 |
| 31 Mar 18 | 3,335 | 173 | 457 | 0 |
| 31 Dec 17 | 2,590 | 111 | 419 | 0 |
| 30 Sep 17 | 3,124 | 173 | 416 | 0 |
| 30 Jun 17 | 3,052 | 176 | 403 | 0 |
| 31 Mar 17 | 2,996 | 176 | 389 | 0 |
| 31 Dec 16 | 2,939 | 166 | 390 | 0 |
| 30 Sep 16 | 3,020 | 134 | 418 | 0 |
| 30 Jun 16 | 3,115 | 136 | 422 | 0 |
| 31 Mar 16 | 3,243 | 153 | 425 | 0 |
| 31 Dec 15 | 2,929 | 148 | 394 | 0 |
| 30 Sep 15 | 3,471 | 127 | 455 | 0 |
| 30 Jun 15 | 3,588 | 115 | 466 | 0 |
양질의 수익: AVNT는 $68.8M 규모의 큰 일회성 손실이 있어 31st March, 2026까지 지난 12개월 재무 결과에 영향을 미쳤습니다.
이익 마진 증가: AVNT의 현재 순 이익률 (4.8%)은 지난해 (3.1%)보다 높습니다.
잉여현금흐름 대비 순이익 분석
과거 순이익 성장 분석
수익추이: AVNT의 수익은 지난 5년 동안 연평균 8.5% 감소했습니다.
성장 가속화: 지난 1년간 AVNT 의 수익 증가율(58%)은 연간 평균(-8.5%)을 초과합니다.
수익 대 산업: AVNT의 지난 1년 수익 증가율(58%)은 Chemicals 업계의 0.7%를 상회했습니다.
자기자본이익률
높은 ROE: AVNT의 자본 수익률(6.6%)은 낮음으로 평가됩니다.
총자산이익률
투하자본수익률
우수한 과거 실적 기업을 찾아보세요
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/05/12 23:18 |
| 종가 | 2026/05/12 00:00 |
| 수익 | 2026/03/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Avient Corporation는 18명의 분석가가 다루고 있습니다. 이 중 8명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Ghansham Panjabi | Baird |
| Prashant Juvekar | Citigroup Inc |
| David Begleiter | Deutsche Bank |